Verastem, Inc. - Common Stock (NQ:VSTM)

9.340 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Verastem, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal ↗

May 25, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company...

Via Benzinga

Verastem Oncology to Present at the 2021 Jefferies Virtual Healthcare Conference

May 25, 2021

From Verastem, Inc.

Via Business Wire

Why Verastem Stock Is Crushing It Today ↗

May 24, 2021

The biotech's experimental cancer treatment won an important regulatory designation today.

Via The Motley Fool

Why Verastem's Stock Is Trading Higher Today ↗

May 24, 2021

Verastem (NASDAQ:VSTM) shares are trading higher...

Via Benzinga

52 Biggest Movers From Yesterday ↗

May 25, 2021

Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 72% to close at $10.25 on Monday after the company reported the FDA approval of IND application for CpG-STAT3siRNA,...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 24, 2021

Gainers Scopus BioPharma (NASDAQ:SCPS) stock rose 101.34% to $12.0 during Monday's regular session. As of 12:30 EST, this security is trading at a volume of 17.5...

Via Benzinga

Verastem's VS-6766/Defactinib Combo Gets Breakthrough Therapy Tag For Ovarian Cancer; BTIG Upgrades Stock ↗

May 24, 2021

The FDA has granted Breakthrough Therapy designation to Verastem Inc (NASDAQ: VSTM) for the combination of its investigational VS-6766, with defactinib,...

Via Benzinga

Stocks That Hit 52-Week Highs On Monday ↗

May 24, 2021

This morning 128 companies set new 52-week highs. Points of Interest: Novo Nordisk (NYSE:NVO) was the biggest firm by market cap to hit a new 52-week high. Taylor...

Via Benzinga

Verastem Oncology Receives Breakthrough Therapy Designation for VS-6766 with Defactinib in Recurrent Low-Grade Serous Ovarian Cancer

May 24, 2021

From Verastem, Inc.

Via Business Wire

Stocks That Hit 52-Week Highs On Friday ↗

May 21, 2021

Friday's morning session saw 160 companies set new 52-week highs. Areas of Significance: The largest company by market cap to set a new 52-week high was AbbVie...

Via Benzinga

The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying ↗

May 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks ↗

May 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 19) ESSA Pharma Inc. (NASDAQ:...

Via Benzinga

Stocks That Hit 52-Week Highs On Thursday ↗

May 20, 2021

Before 10 a.m. ET Thursday, 56 stocks made new 52-week highs. Intriguing Points: The largest company by market cap to hit a new 52-week high was Novo Nordisk (NYSE:...

Via Benzinga

Verastem Oncology Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress

May 11, 2021

From Verastem Oncology

Via Business Wire

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗

April 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.